thioridazine derivatives (University of Padua/Istituto Di Ricerca Pediatrica Città Della Speranza/Bambino Gesù Children’s Hospital IRCCS)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namethioridazine derivatives (University of Padua/Istituto Di Ricerca Pediatrica Città Della Speranza/Bambino Gesù Children’s Hospital IRCCS)

Drug Alias NameHistone lysine methyltransferase 2A inhibitors (University of Padua/Istituto Di Ricerca Pediatrica Città Della Speranza/Bambino Gesù Children’s Hospital IRCCS)TDZ-6

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionVoltage-gated calcium channel modulatorsHistone-lysine N-methyltransferase 2A inhibitors

TargetsVoltage-gated calcium channelHistone-lysine N-methyltransferase 2A

Therapy Area/IndicationsLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Padova

China Registration ClassN/A

Develop Information

Active CompaniesIstituto Di Ricerca Pediatrica Città Della Speranza Ospedale Pediatrico Bambino Gesu University Of Padova

Inactive CompaniesN/A

Active IndicationsLeukemia, Myeloid, Acute

Inactive IndicationsN/A

Other Information

ATC CodeN/A